224 related articles for article (PubMed ID: 33229426)
1. Discovery of Amoebicidal Compounds by Combining Computational and Experimental Approaches.
Sebastián-Pérez V; Sifaoui I; Reyes-Batlle M; Domínguez-De Barros A; López-Arencibia A; Campillo NE; Piñero JE; Lorenzo-Morales J; Gil C
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33229426
[TBL] [Abstract][Full Text] [Related]
2. Malabaricones from the fruit of Myristica cinnamomea King as potential agents against Acanthamoeba castellanii.
Ahmed U; Sivasothy Y; Khan KM; Khan NA; Wahab SMA; Awang K; Othman MA; Anwar A
Acta Trop; 2023 Dec; 248():107033. PubMed ID: 37783284
[TBL] [Abstract][Full Text] [Related]
3. (‒)-Epicatechin reveals amoebicidal activity against Acanthamoeba castellanii by activating the programmed cell death pathway.
Lê HG; Kang JM; Võ TC; Yoo WG; Hong Y; Na BK
Phytomedicine; 2024 Mar; 125():155389. PubMed ID: 38306720
[TBL] [Abstract][Full Text] [Related]
4. Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris.
Kulsoom H; Baig AM; Siddiqui R; Khan NA
Exp Parasitol; 2014 Nov; 145 Suppl():S115-20. PubMed ID: 24726699
[TBL] [Abstract][Full Text] [Related]
5. Antiamoebic activity of 3-aryl-6,7-dimethoxyquinazolin-4(3H)-one library against Acanthamoeba castellanii.
Shahbaz MS; Anwar A; Saad SM; Kanwal ; Anwar A; Khan KM; Siddiqui R; Khan NA
Parasitol Res; 2020 Jul; 119(7):2327-2335. PubMed ID: 32476058
[TBL] [Abstract][Full Text] [Related]
6. Artemether Exhibits Amoebicidal Activity against Acanthamoeba castellanii through Inhibition of the Serine Biosynthesis Pathway.
Deng Y; Ran W; Man S; Li X; Gao H; Tang W; Tachibana H; Cheng X
Antimicrob Agents Chemother; 2015 Aug; 59(8):4680-8. PubMed ID: 26014935
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B.
Taravaud A; Loiseau PM; Pomel S
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):328-336. PubMed ID: 28918001
[TBL] [Abstract][Full Text] [Related]
8. Lactase can target cellular differentiation of Acanthamoeba castellanii belonging to the T4 genotype.
Simau FA; Ahmed U; Khan KM; Khan NA; Siddiqui R; Alharbi AM; Alfahemi H; Anwar A
Parasitol Res; 2024 Jan; 123(2):117. PubMed ID: 38294565
[TBL] [Abstract][Full Text] [Related]
9. Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles.
Anwar A; Yi YP; Fatima I; Khan KM; Siddiqui R; Khan NA; Anwar A
Parasitol Res; 2020 Jun; 119(6):1943-1954. PubMed ID: 32385711
[TBL] [Abstract][Full Text] [Related]
10. Potential anti-acanthamoebic effects through inhibition of CYP51 by novel quinazolinones.
Ahmed U; Ho KY; Simon SE; Saad SM; Ong SK; Anwar A; Tan KO; Sridewi N; Khan KM; Khan NA; Anwar A
Acta Trop; 2022 Jul; 231():106440. PubMed ID: 35378058
[TBL] [Abstract][Full Text] [Related]
11. Isobenzofuran-1(3H)-one derivatives: Amoebicidal activity and program cell death in Acanthamoeba castellanii Neff.
Rodríguez-Expósito RL; Reyes-Batlle M; Sifaoui I; Tejedor D; García-Tellado F; Piñero JE; Lorenzo-Morales J
Biomed Pharmacother; 2022 Jun; 150():113062. PubMed ID: 35658232
[TBL] [Abstract][Full Text] [Related]
12. Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages.
Anwar A; Soomaroo A; Anwar A; Siddiqui R; Khan NA
Exp Parasitol; 2020 Aug; 215():107915. PubMed ID: 32461112
[TBL] [Abstract][Full Text] [Related]
13. Methanolic extract of Peganum harmala exhibit potent activity against Acanthamoeba castellanii cysts and its encystment in vitro.
Shohaib HM; Nawaz S; Matin A
Pak J Pharm Sci; 2016 Nov; 29(6):1993-1996. PubMed ID: 28375115
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect.
Sharma G; Kalra SK; Tejan N; Ghoshal U
Exp Parasitol; 2020 Nov; 218():108008. PubMed ID: 32979343
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
Martín-Navarro CM; López-Arencibia A; Arnalich-Montiel F; Valladares B; Piñero JE; Lorenzo-Morales J
Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2111-7. PubMed ID: 23686225
[TBL] [Abstract][Full Text] [Related]
16. Applications of medicinal chemistry for drug discovery against Acanthamoeba infections.
Ahmed U; Anwar A; Ong SK; Anwar A; Khan NA
Med Res Rev; 2022 Jan; 42(1):462-512. PubMed ID: 34472107
[TBL] [Abstract][Full Text] [Related]
17. Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii.
Anwar A; Numan A; Siddiqui R; Khalid M; Khan NA
Parasit Vectors; 2019 Jun; 12(1):280. PubMed ID: 31159839
[TBL] [Abstract][Full Text] [Related]
18. In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts.
Debnath A; Tunac JB; Silva-Olivares A; Galindo-Gómez S; Shibayama M; McKerrow JH
Antimicrob Agents Chemother; 2014; 58(3):1523-8. PubMed ID: 24366747
[TBL] [Abstract][Full Text] [Related]
19. Anti-amoebic effects of synthetic acridine-9(10H)-one against brain-eating amoebae.
Ahmed U; Manzoor M; Qureshi S; Mazhar M; Fatima A; Aurangzeb S; Hamid M; Khan KM; Khan NA; Rashid Y; Anwar A
Acta Trop; 2023 Mar; 239():106824. PubMed ID: 36610529
[TBL] [Abstract][Full Text] [Related]
20. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
Rice CA; Colon BL; Chen E; Hull MV; Kyle DE
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008353. PubMed ID: 32970675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
